Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
  • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
  • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
  • A61K35/14—Blood; Artificial blood
  • A61K35/16—Blood plasma; Blood serum
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K39/02—Bacterial antigens
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K39/12—Viral antigens
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N7/00—Ultrasound therapy
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
  • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
  • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
  • A61K2039/525—Virus
  • A61K2039/5252—Virus inactivated (killed)

Definitions

• the dead pathogens are injected or looped back along with a donor's healthy blood of the same type of patient's blood to the same patient.
• the advantage of this procedure is that the leukocytes encounter the dead pathogens and eliminate it, and in this way the leukocytes will learn the protein structure of the pathogen, inside the body of the patient. Now that leukocytes
• my invention includes hyperactivating the immune system of a patient. So far there has not been any artificial way to hyperactivate immune system. I call this procedure remote loop back. A very small sample of a donor's healthy skin tissue, as much as tip of biopsy, entered in patient's blood stream, along with some healthy blood of a donor that is the same type of patient's blood. Skin tissues are really harmless to the body of a patient. But since leukocytes detect a foreign cell, they attack the donor's skin cell. This matter is communicated to immune system. The immune system then has to create more leukocytes to combat the foreign cells.
• My goal in this patent application is to detect pathogens in human body, animals, plants, water bodies, and the air, without blood test or any sampling. I have also aimed to eliminate pathogens, and cancer genes in humans and animals, by creating innovating procedures. The pathogens in air, in open spaces, plants and, water bodies could also be eliminated. I have also aimed to hyperactivate body's immune system.
• My inventions comprising detection and scanning for pathogens by their spectral signature which requires no blood test.
• Each molecule or pathogen has a unique spectral signature.
• I have approached the treatment problem by the electrostatic properties of the pathogens. All known pathogens are negatively charged.
• the cancer genes have either positive or negative charges.
• Skin tissues are really harmless to the body of a patient. But since leukocytes detect a foreign cell, they attack the donor's skin cell. This matter is communicated to immune system. The immune system then, has to create more leukocytes to combat the foreign cells. For example, covid-19 attacks and kill certain types of leukocytes, but by doing this, this pathogen dies too. New and fresh supply of leukocytes is apparent here.
• the ultrasound is virtually harmless to a patient's body, but it is deadly to pathogens.
• Ultrasound is used for eliminating pathogens inside organs and tissues for animals and humans. This is a great way to combat pathogens such as covid-19 or C Diff Colitis, which are also known to exist in body tissues and organs, besides the blood. Ultrasound also eliminates the pathogens feeding off of body cells and creating genomes to replicate themselves. Therefore, ultrasound kills genomes of pathogens too. Best example of these kinds of pathogens is covid-19, infesting in pulmonary and digestive systems, etc. So, this method is included in my patent application.
• My goal in this patent application is to detect disease causing pathogens in human body, animals, water bodies, and the air in living spaces, without blood test or any sampling.
• the pathogens in air in living spaces, plants and, water bodies could also be eliminated.
• My inventions comprising detection and scanning for disease pathogens by their spectral signature which requires no blood test.
• Pathogens of any disease have a unique spectral signature.
• the spectral signatures of all of pathogens known will be stored in a device that I call HPC Device 1H.
• the processor within HPC Device 1H after scanning the patient will decide if the observed spectral signature matches to any pathogens within the database.
• device HPC 1H will alert that the patient has that specific pathogen in their body. See FIG. 1 for this device.
• This device has an infrared sensor for focusing on say an organ. The operator will observe the monitor to see a representation of that organ is within the screen limit.
• HPC device 1H could emit Ultraviolet waves or X-rays on that focused organ. I prefer
• Ultraviolet A 100 watts Ultraviolet emitter or 50 watts X-ray emitter will give clear spectral images, while not harming the patient's body. Above these 2 settings for emitter power mentioned above may be harmful to patient. Below these 2 settings for emitter power mentioned above may be yielding blurry or, low quality spectral images. I prefer ultraviolet since it is less harmful than X-rays. At a 5 second Ultraviolet emission, 1000 scans taken. The spectral signature emitting from body is observed by HPC device 1H, to match for any pathogens in HPC Device lH's database.
• the organs selected for example for covid-19 are the lungs, breathing paths, lower Gl, and neural paths etc.
• the doctor will decide what organs need to be scanned for the pathogens, as well.
• a scan of an entire arm from shoulder up to the border with hand is done also, to detect the pathogens within patient's blood stream.
• This same scanner-detector is used to detect pathogens inside an animal's body.
• HPC Device 1W is used for water
• HPC Device 1A is used for air. See figures 2 and 3.
• HPC Device 1A could emit Ultraviolet waves or X-rays for spectral analysis.
• Emitter powers are indicated in following sentences.
• a 10KW Ultraviolet emitter is chosen. At a 5 second emission, 1000 scans taken. The spectral signature emitting from Air is observed by this device i.e.
• HPC Device 1A to match for any pathogens in HPC Device lA's database.
• HPC device 1A scans up to 2 miles in any directions. If X-rays are chosen for HPC Device 1A, the power of emitter is 5KW and can detect up to 2 miles radius. HPC Device 1W is used for water. If X-rays
• HPC Device 1W the power of emitter is 50KW and can detect up to 2 miles radius. The emitter goes into water about one meter below air surface and can scan up to 2 miles in any direction in the water, on a semi sphere area. For better quality of spectral images one meter is maximum depth that emitter submerge in water.
• HPC Device 1W could emit Ultraviolet waves or X-rays for spectral analysis for water. I prefer to use Ultraviolet. A 100KW Ultraviolet emitter is chosen. At a 5 second emission, 1000 scans taken. The spectral signature emitting from water is observed by HPC device 1W, to match for any pathogens in HPC device lW's database.
• Jar 10 has an opening on top, blood flows through a phlebotomy hose into the jar 10. This continues until the jar 10's lid is fully contacting blood. At that time the phlebotomy valve is turned, to stop blood flow into jar 10.
• white cell loss, plasma loss administer 1000 mg of vitamin C, at the same time as treatment, patient is receiving an IV solution of water, and plasma, please also see remote loop back procedure mentioned in [0021] .
• Jar 10 is made of an alloy of copper- aluminum. By anodizing method, that is normally used for industrial use, this jar is processed to have pores of different sizes depending on disease. A special anodizing method is necessary that I mentioned the highlights in paragraph [0014] The lid of this jar is not usually anodized,
• a dielectric material such as flexible plastics is used to make sure that the lid and jar have no contacts.
• the lid is connected to the negative side of DC power supply, and the jar itself is to positive side of same power supply.
• the power supply has two modes 25 V or 50 V, either way the total power output is 100 W for best results.
• 25 V setting it takes about 24 hours to completely deplete the blood from pathogen considered.
• 50 V setting it takes 12 hours to do the same.
• 25 V setting is healthier for patients.
• the pathogens and their genomes will be attracted to the walls of the jar, including the bottom wall, while the lid of jar 10 repels them.
• the pores inside jar 10 are twice the size of pathogen considered. For example, if the size of a hypothetical pathogen is 150 nm then pores created inside jar 10 are selected to be 300 nm.
• the pathogens are infesting inside of some of white cells. In that case an additional jar needed that is anodized to have a size of pores twice size of contaminated white cells. Obviously, the infested white cells will be negatively charged.
• HPC Device 1H of [0002] shows no sign of pathogens inside jar 10 then, continue with electrostatic cleansing of blood in jar 10 for 4 jars more. This is for cases that the pathogens might me hiding in odd places. Before, sending patient home, it is better to double check by proper blood test and checking by HPC Device 1H of [0002] Also, for diseases like corona, or C Diff colitis that pathogens hide inside tissues and organs see [0015] i.e. HPC Device 3 and, HPC Device 4 of [0023]
• Anodizing is a known industrial process. To custom design for this invention I have selected some special considerations to fit the purpose of catching pathogens. This way this industrial process could have a new use and hence nobility for medical science.
• the highlights for anodizing for this invention is as follows: I have chosen an alloy of Copper- Aluminum/doping. Reason for alloy/doping is to make pores bigger than usual, when necessary. A jar of lpint capacity in cubic shape to be made from this alloy. Before anodizing and then
• HPC Device 3 uses electrostatic property of pathogens and their genomes to capture them. If Dr recommends or if device 1 HPCH recognizes pathogens or their genomes inside a tissue or organ, HPC Device 3 can extract pathogens or their genomes.
• This device comprising two needles, like syringe needles. These needles are made of an alloy of tungsten available in some specialty vendors and are 36 gauge. Both needles are 5 inches long. There are 5 small grooves at the tip of one of the two needles. These 5 grooves have a 45 degrees angle with respect to the body of needle. These 5 grooves go to the main hollow track of needle. The grooves are created by specialty vendors by fine beam lasers.
• This needle is attached to positive part of a power supply.
• the body of this needle is rough, so are the insides of the 5 grooves and the main track of needle. The reason for this roughness is that negatively charged pathogens and genomes get attracted and attached to positive side needle, we want them to stay attached and not break free.
• the other needle is simple, no main track or grooves inside, and has smooth surface. This needle is connected to negative part of power supply. I
• HPC Device 19 have chosen voltage setting on power supply to be either set to 25 or 50 volts. However, voltages between 25 V to 100 V works. Above 100 V is unhealthy for patient. Below 25 V is not effective. The power output of power supply is 100 W for 50 volts, and power output is 50 watts for 25 volts. I prefer to use 50 V option. This option is more effective.
• HPC Device 3 After cleansing of blood by HPC Device 2, if HPC Device 4, mentioned in [0023] could not kill pathogens inside an organ by ultrasound, then say in a month later, HPC Device 3 can pull out the pathogen and their genomes. This procedure involves incision of 2 needles mentioned above with in 2 mm of each other. The general location of pathogens and their genomes is determined by HPC Device 1H.
• HPC Device 3 can catch a considered pathogen and its genomes, due to electrostatic attraction between needle attached to positive side of power supply and negatively charged pathogens and genomes. A general location within 2 mm is fine for incision. Also, there is a repelling force between needle attached to negative side of power supply and pathogens or genomes. The repelling force helps the positive needle to attract the pathogen or genome better. Best is, if possible, to make incision so that pathogen or genome are located between two needles currently finding infinitesimal pathogens and genomes is close to impossible. However, using this device, you can even pull out genomes in one piece. This procedure is relatively nonabrasive and harmless. Usually after 10 trials even genomes come out in one piece. Note: any organ treated, might need anti swelling-anti inflammation medication. Genomes and pathogens could be cultured in a lab, then frozen at -60 degrees Fahrenheit for use at a later time.
• the power supply used has an output of 50 volts and 100 watts. Any other voltage or power either won't work or will do more damage.
• Start incision at appearance location of cancer For example, say for liver usually cancerous cells create swelling on spots on liver. The spots are starting point for incision.
• Trick is that cancer causing genes can be either positive or negative.
• both needles are same kind as the positive side needle of this device in [0015] Both needles have rough surfaces inside the 5 grooves. Both needles have rough surfaces inside the main track. Both needles have rough outer surfaces. The reason for roughness of surfaces has been explained before. One can see the voltage indicator on power supply to get spikes and very infinitesimal drop in voltage. This voltage drop is in microvolts.
• Device 3 for cancer spots/ or genes floating in blood For any cancer, specially leukemia recommended course of action is to start with device 2 HPC. We want to catch genes in blood and infested cells with genes. The jar in this case is divided into two halves one half will connect to positive, and the other to negative side of the 100 watts, 50 volts power supply. The halves are separated with a dielectric material such as plastics. This way infested blood cells and genes can be captured. Obviously, the pores are twice the size of biggest blood cells in question. Obviously, a blood - plasma transfusion is extremely helpful, especially for leukemia. Simultaneously HPC Device 3 is used to search inside of other organs for cancer, that might not have started inflammation or swelling inside.
• Covid-19 is an example of this category. Local loop back works for both serum and vaccination for covid-19. This serum or vaccine will not work for aids. A small sample of 1 mL of sick patient's blood is taken and the pathogens within that sample are killed. Caution must be taken that the protein coding is not damaged. Then, the dead pathogens are injected through IV or looped back along with a pint of a donor's healthy blood, that is same type as patient's blood to patient. This is the vaccine treatment. For serum there are 4 more stages needed. In first stage above, we used completely dead pathogens along with fully dead genomes of that pathogen, when that pathogen multiplies inside of cells of organs.
• Stage 2 2 days after stage 1 use a mixture of, 90% fully dead, 5% of 3 ⁇ 4 dead and 5% half dead pathogens also fully dead genomes of that pathogen, when that pathogen multiplies inside of cells of organs, in one pint of a healthy donor's blood, same as patient's type blood.
• Stage S 2 days after stage 2 use a mixture of, 90% fully dead, 5% of 3 ⁇ 4 dead, 5% half dead, and 20 counts of 1 ⁇ 4 dead pathogens, also fully dead genomes of that pathogen, when that pathogen multiplies inside of cells of organs, in one pint of a healthy donor's blood, same type as patient's type blood.
• Stage 4 2 days after stage S
• Remote loop back my invention includes hyperactivating the immune system of a patient. I call this procedure remote loop back. This method is useful to apply at the same time as vaccination or applying serum. Vitamin C is known to increase number of leukocytes, this
• Skin tissues are really harmless to the body of a patient. But since leukocytes detect a foreign cell, they attack the donor's skin cells. This matter is communicated to immune system. The immune system then has to create more leukocytes to combat the foreign cells. For example, covid-19 attacks and kill certain types of leukocytes, but by doing this attack, this pathogen dies too. The need for new and fresh supply of leukocytes is apparent here.
• HPC Device 4 The ultrasound is virtually harmless to a patient's body, but it is deadly to pathogens. This is a great way to combat pathogens such as covid-19 or C Diff Colitis, which are also known to exist in body tissues and organs, besides the blood. Ultrasound also eliminates the pathogens feeding off of body cells and creating genomes to replicate themselves. Therefore, ultrasound kills these genomes of pathogens too. Best example of these kinds of pathogens is covid-19, infesting in pulmonary systems, breathing tracks, digestive systems, etc. So, this method is included in my patent application. The only thing is, general anesthesia is necessary, since ultrasound causes severe pain. See Fig. 6 for ultrasound device that I have invented. I call this, HPC Device 4.
• HPC Device 4 The power output of HPC Device 4 is 100 Watts. Say you want to kill covid-19 virus and virus's genomes infesting in few spots on lungs. Note that genomes of say covid-19 have a different spectral signature than the spectrum of whole covid- 19 virus.
• HPC Device 1H is used to indicate the infested spots. In this example every spot of lungs is treated, one at a time. In this example metal side of the applicator is placed on top of the locations of lungs on skin surface that HPC Device 1H has indicated. You rub the metal side
• any sign of these signatures means repeating cleansing of blood and organ. This continues until all related covid-19 spectral signatures do not show on HPC Device 1H, and also the last 4 samples of blood shows, no sign of covid-19, that is revealed by spectral signature in HPC Device 2's jar 10 explained in [0013] After ultrasound treatment remote loop back of [0022] may be drastically useful. Also, anti-inflammation, and anti-swelling medications are strongly recommended, specially during use of this procedure, and a few days after, by Dr's discretion, checking for allergies for these kinds of medications; for treatment of lungs this might be crucial.
• FIG. 1 HPC device 1H detects pathogens in humans or animals.
• FIG. 2 HPC device 1A detects pathogens in air.
• FIG. 3 HPC device 1W detects pathogens in water.
• FIG. 4 HPC device 2 cleans blood from pathogens.
• FIG. 5 FI PC device 3
• FIG. 6 FI PC device 4

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Medicinal Chemistry (AREA)
• Chemical & Material Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Epidemiology (AREA)
• Immunology (AREA)
• Engineering & Computer Science (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Biomedical Technology (AREA)
• Cell Biology (AREA)
• Hematology (AREA)
• Virology (AREA)
• Mycology (AREA)
• Microbiology (AREA)
• Radiology & Medical Imaging (AREA)
• Communicable Diseases (AREA)
• Organic Chemistry (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Oncology (AREA)
• Biotechnology (AREA)
• Developmental Biology & Embryology (AREA)
• Zoology (AREA)
• Apparatus For Disinfection Or Sterilisation (AREA)
• Manufacture And Refinement Of Metals (AREA)
• Medicines Containing Plant Substances (AREA)
• Ceramic Products (AREA)
• Computer Vision & Pattern Recognition (AREA)
• Physics & Mathematics (AREA)
• Biophysics (AREA)
• Pathology (AREA)
• Heart & Thoracic Surgery (AREA)
• Medical Informatics (AREA)
• Molecular Biology (AREA)
• Surgery (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=78745078

Family Applications (1)

Country Status (5)

Family Cites Families (4)

• 2020
  • 2020-06-05 WO PCT/US2020/036478 patent/WO2021242279A1/en unknown
  • 2020-06-05 JP JP2022573712A patent/JP2024510057A/ja active Pending
  • 2020-06-05 AU AU2020450947A patent/AU2020450947A1/en active Pending
  • 2020-06-05 EP EP20937771.2A patent/EP4237075A1/en active Pending
  • 2020-06-05 KR KR1020227044856A patent/KR20230041660A/ko unknown

Also Published As

Similar Documents

Legal Events